Condition: Chronic Kidney Diseases · Sponsor: University of California, Los Angeles
We will conduct a 12-month, double-blind, randomized, placebo-controlled trial to assess the effects of therapy with ferric citrate (FC) on changes in intact FGF23 levels (iFGF23, primary endpoint) in 160 pediatric patients (80 in each of the two arms) aged 6-18 years of either sex with chronic kidney disease (CKD) stages 3-4 and age-appropriate normal serum phosphate levels. Participants will be randomized to one of the two groups: 1) FC or 2) FC placebo. Participants will be recruited from 20 core clinical sites.
This description comes directly from the study's public registry record.
JENNY BROOK, MS · 310-7943144 · jbrook@mednet.ucla.edu
Barbara Gales, RN · 310-206-0799 · bgales@mednet.ucla.edu
Always discuss trial participation with your own doctor first.
| University of California, Los Angeles | Los Angeles, California, United States | Recruiting |
| Children's Hospital of Orange County | Orange, California, United States | Recruiting |
| University of California, San Francisco | San Francisco, California, United States | Recruiting |
| Arnold Palmer Hospital for Children | Orlando, Florida, United States | Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| Indiana U | Indianapolis, Indiana, United States | Recruiting |
| Children's Mercy Hospital, Kansas City | Kansas City, Missouri, United States | Recruiting |
| Washington U | St Louis, Missouri, United States | Recruiting |
| Cohen's Childrens | New York, New York, United States | Recruiting |
| Children's Hospital at Montefiore | The Bronx, New York, United States | Recruiting |
| Duke | Durham, North Carolina, United States | Not Yet Recruiting |
| Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States | Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04741646